sōna Aspergillus Galactomannan LFA
sōna Aspergillus Galactomannan LFA
Over 30 million people are at risk of invasive aspergillus infection each year because of corticosteroid use or other therapies, and over 300,000 patients develop invasive aspergillosis annually.
shared：
Name：sōna Aspergillus Galactomannan LFA
REF：AF2003
Size: 50 Tests
Brand: IMMY
Origin: US
The disease is common in high risk patients with:
● Hematological malignancies
● Chemotherapy-induced neutropenia
● Allogeneic HSCT (stem cell transplant)
● Solid organ transplant (primarily lung)
Key Advantages of the Aspergillus GM LFA:
● 30 Minute test time
● Simplified procedure
● High sensitivity and specificity
● Serum & BAL specimens
● Test more frequently/Eliminate batch testing
Procedure:
Percent Agreement to Commercially Available Antigen EIA:
Read more： https://www.immy.com/asp
- Name
- Phone
- Corporate name
- Address
- Leaving Message*
